Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ BLA36 Monoclonal Antibody (EBS-T-002)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA533326

Catalog No. PIMA533326


Only null left
Add to Cart

Description

Description

BLA36 is a developmentally regulated 36 kDa antigen expressed on the plasma membrane of B lymphocytes, Reed-Sternberg, and mononuclear Hodgkin's cells. It also gives strong staining of B cell lymphomas including follicular center cell lymphomas (large and small cell types), mantle zone lymphomas, and immunoblastic lymphomas.

BLA.36 is a developmentally regulated 36 kDa antigen expressed on the plasma membrane of B lymphocytes, Reed-Sternberg, and mononuclear Hodgkin's cells. The anti-BLA.36 antibody recognizes all four subtypes of Hodgkin's disease and gives strong staining of B cell lymphomas including follicular center cell lymphomas (large and small cell types), mantle zone lymphomas, and immunoblastic lymphomas. Anti-BLA.36 can be used to distinguish Reed-Sternberg cells and some B-cell lymphomas from other malignant cells.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

BLA36
Monoclonal
100 μg/mL
PBS with 0.02% sodium azide
Mouse
Protein A/G
RUO
Human
Antibody
IgG1 κ
Immunohistochemistry (Frozen)
EBS-T-002
Unconjugated
BLA36
Human BLA36 recombinant protein.
100 μg
Primary
4°C, do not freeze
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.